Australian biotech scale-up Microbio has started commercial evaluation trials in Ecuador prior to launching its flagship InfectID-BSI (Bloodstream Infection) test in South America.
Read more in the media release: 221019 Microbio conducts commercial evaluation trials in Ecuador